Herborium Group Inc
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company offers dermatology products, which include AcnEase, an herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for… Read more
Herborium Group Inc (HBRM) - Net Assets
Latest net assets as of August 2025: $-2.57 Million USD
Based on the latest financial reports, Herborium Group Inc (HBRM) has net assets worth $-2.57 Million USD as of August 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($150.20K) and total liabilities ($2.72 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.57 Million |
| % of Total Assets | -1708.99% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 131.15 |
Herborium Group Inc - Net Assets Trend (1998–2024)
This chart illustrates how Herborium Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Herborium Group Inc (1998–2024)
The table below shows the annual net assets of Herborium Group Inc from 1998 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-11-30 | $-3.96 Million | +8.34% |
| 2023-11-30 | $-4.32 Million | -9.08% |
| 2022-11-30 | $-3.96 Million | -3.19% |
| 2021-11-30 | $-3.83 Million | -662.00% |
| 2020-11-30 | $-503.20K | +9.48% |
| 2019-11-30 | $-555.90K | -15.74% |
| 2018-11-30 | $-480.30K | -31.81% |
| 2017-11-30 | $-364.40K | -33.58% |
| 2016-11-30 | $-272.80K | -25.37% |
| 2015-11-30 | $-217.60K | +27.99% |
| 2014-11-30 | $-302.20K | +79.63% |
| 2011-11-30 | $-1.48 Million | -14.11% |
| 2010-11-30 | $-1.30 Million | +21.29% |
| 2009-11-30 | $-1.65 Million | -4.36% |
| 2008-11-30 | $-1.58 Million | -38.34% |
| 2007-11-30 | $-1.14 Million | -58.28% |
| 2006-11-30 | $-722.95K | +61.65% |
| 2005-11-30 | $-1.89 Million | -396.62% |
| 2004-11-30 | $635.50K | -59.63% |
| 2003-11-30 | $1.57 Million | -64.56% |
| 2002-11-30 | $4.44 Million | -39.08% |
| 2001-11-30 | $7.29 Million | -26.03% |
| 2000-11-30 | $9.86 Million | +1.25% |
| 1999-11-30 | $9.74 Million | +11.34% |
| 1998-11-30 | $8.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Herborium Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 302.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (November 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $10.92 Million | % |
| Total Equity | $-4.30 Million | 100.00% |
Herborium Group Inc Competitors by Market Cap
The table below lists competitors of Herborium Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Firma Holdings Corp
PINK:FRMA
|
$0.95 |
|
Thresher Industries Inc
PINK:THRR
|
$0.95 |
|
Sunset Capital Assets Inc
PINK:SNST
|
$0.95 |
|
All World Resources Corporation
PINK:AWRS
|
$0.96 |
|
Perla Group International Inc
PINK:PERL
|
$0.95 |
|
Airborne Security & Protective Services Inc
PINK:ABPR
|
$0.95 |
|
Transwitch Cp New
PINK:TXCCQ
|
$0.95 |
|
RBID.com Inc
PINK:RBDC
|
$0.95 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Herborium Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -4,315,643 to -4,298,633, a change of 17,010.
- Net loss of 328,770 reduced equity.
- Other comprehensive income increased equity by 10,919,428.
- Other factors decreased equity by 10,573,648.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-328.77K | -7.65% |
| Other Comprehensive Income | $10.92 Million | +254.02% |
| Other Changes | $-10.57 Million | -245.98% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Herborium Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-11-30 | $0.92 | $0.00 | x |
| 1999-11-30 | $0.96 | $0.00 | x |
| 2000-11-30 | $0.98 | $0.00 | x |
| 2001-11-30 | $0.71 | $0.00 | x |
| 2002-11-30 | $0.42 | $0.00 | x |
| 2003-11-30 | $0.15 | $0.00 | x |
| 2004-11-30 | $0.06 | $0.00 | x |
| 2006-11-30 | $-0.01 | $0.00 | x |
| 2007-11-30 | $-0.01 | $0.00 | x |
| 2016-11-30 | $0.00 | $0.00 | x |
| 2017-11-30 | $0.00 | $0.00 | x |
| 2018-11-30 | $0.00 | $0.00 | x |
| 2019-11-30 | $0.00 | $0.00 | x |
| 2020-11-30 | $0.00 | $0.00 | x |
| 2021-11-30 | $0.00 | $0.00 | x |
| 2022-11-30 | $0.00 | $0.00 | x |
| 2023-11-30 | $0.00 | $0.00 | x |
| 2024-11-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Herborium Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -31.28%
- • Asset Turnover: 6.69x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-21.08%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 20.31% | 1.68% | 4.99x | 2.41x | $901.23K |
| 1999 | 8.50% | 0.79% | 5.07x | 2.13x | $-146.30K |
| 2000 | 1.24% | 0.14% | 4.26x | 2.12x | $-863.98K |
| 2001 | -39.10% | -3.80% | 4.33x | 2.38x | $-3.58 Million |
| 2002 | -63.84% | -4.03% | 4.07x | 3.89x | $-3.28 Million |
| 2003 | -135.21% | -2.86% | 5.03x | 9.38x | $-2.29 Million |
| 2004 | -297.75% | -2.65% | 6.09x | 18.47x | $-1.96 Million |
| 2006 | 0.00% | -41.05% | 7.00x | 0.00x | $-267.46K |
| 2007 | 0.00% | -84.34% | 9.70x | 0.00x | $-528.13K |
| 2008 | 0.00% | -221.13% | 2.77x | 0.00x | $-741.70K |
| 2009 | 0.00% | -434.56% | 2.07x | 0.00x | $-777.80K |
| 2010 | 0.00% | -220.52% | 2.83x | 0.00x | $-447.72K |
| 2011 | 0.00% | -104.78% | 2.75x | 0.00x | $-97.22K |
| 2014 | 0.00% | -16.90% | 2.91x | 0.00x | $-85.28K |
| 2015 | 0.00% | -12.22% | 3.63x | 0.00x | $-65.28K |
| 2016 | 0.00% | -6.49% | 4.86x | 0.00x | $-27.42K |
| 2017 | 0.00% | -3.54% | 4.84x | 0.00x | $4.30K |
| 2018 | 0.00% | -21.33% | 3.56x | 0.00x | $-126.16K |
| 2019 | 0.00% | -8.69% | 5.06x | 0.00x | $-20.46K |
| 2020 | 0.00% | 4.74% | 4.81x | 0.00x | $97.42K |
| 2021 | 0.00% | -31.28% | 6.18x | 0.00x | $54.67K |
| 2022 | 0.00% | -23.57% | 6.47x | 0.00x | $128.61K |
| 2023 | 0.00% | 2.64% | 7.16x | 0.00x | $461.09K |
| 2024 | 0.00% | -31.28% | 6.69x | 0.00x | $101.09K |
Industry Comparison
This section compares Herborium Group Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Herborium Group Inc (HBRM) | $-2.57 Million | 20.31% | N/A | $0.95 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |